
William E Boden MD FACC, FAHA, FESC, FASPC
Non-Invasive Cardiology, Preventive Cardiology
Scientific Director, Clinical Trials Network, VA Boston Healthcare System; Professor of Medicine, Boston University School of Medicine; Lecturer in Medicine, Harvard Medical School, Boston, Massachusetts
Join to view full profile
150 S. Huntington AvenueBoston, MA 02130
Phone+1 781-400-6553
Fax+1 857-364-5613
Dr. Boden is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William E. Boden is Professor of Medicine at Boston University School of Medicine and Lecturer in Medicine, Harvard Medical School, in Boston, Massachusetts. He is the Physician Research Lead for the New England VA Healthcare System and as the Scientific Director of the Clinical Trials Network, which is based at the VA Boston campus. He is also a Senior Investigator at the VA Boston’s Massachusetts Veterans Epidemiology, Research, and Informatics Center (MAVERIC).
Dr. Boden’s principal research interests include studies in ischemic heart disease, post-MI secondary prevention, acute coronary syndromes, and dyslipidemia in post-MI and coronary artery disease (CAD). Dr. Boden has been involved in clinical research investigator activities as the project director, study chairman and co-chairman for multicenter clinical trials, and served as a principal investigator, steering committee member, and consultant for numerous clinical research grant activities funded by the Department of Veterans Affairs, the NIH, and industry. He was the study chairman for the VANQWISH, INTERCEPT, the landmark COURAGE Trial, and more recently, a national co-PI on the NIH-funded ISCHEMIA Trial.
Dr. Boden has lectured widely (both nationally and internationally) and has written over 450 peer-reviewed publications, original articles, books, chapters, and abstracts. He has been selected as one of the Best Doctors in America continuously since 2003. He is a member of several professional Cardiology organizations and editorial boards. He is Deputy Editor for the J. Clin. Lipidology, an Associate Editor of the European Heart Journal Journal and a member of the editorial board of Journal of Cardiovascular Pharmacology and Therapeutics. He serves as an adhoc reviewer for many journals including the N. Engl. J. Med., JAMA, JAMA Cardiol., JACC, Circulation, Am. Heart J., the Lancet, Ann. Intern. Med., Am J. Med., and many others
Education & Training
Tufts Medical CenterFellowship, Cardiovascular Disease, 1977 - 1979
Boston University Medical CenterResidency, Internal Medicine, 1974 - 1977
SUNY Upstate Medical UniversityClass of 1974
Certifications & Licensure
NY State Medical License 1997 - 2027
VA State Medical License 2011 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Best Doctors in America 2015
- FAHA American Heart Association, 2006
Clinical Trials
- Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Start of enrollment: 1998 Dec 01
- Niacin Plus Statin to Prevent Vascular Events Start of enrollment: 2005 Sep 01
Publications & Presentations
PubMed
- Early combination therapy for angina pectoris: How COMBINE offers new management insights to an old drug.Mathew S Lopes, William E Boden
International Journal of Cardiology. 2026-03-15 - 1 citationsInvasive and medical management approaches to non-acute myocardial ischaemic syndromes.Nicholas Chiu, Deepak L Bhatt, Raffaele De Caterina, Torsten Doenst, Hristo Kirov
Nature Reviews. Cardiology. 2026-02-19 - Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial.Harvey D White, Sean M O'Brien, William E Boden, Stephen E Fremes, Sripal Bangalore
American Heart Journal. 2025-11-01
Journal Articles
- Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe IschemiaMichael H Picard, Raymond Y Kwong, William E Boden, David J Maron, Judith S Hochman, JAMA Cardiology
Abstracts/Posters
- [Board 372] Association Between Low Baseline Testosterone Levels and Adverse Clinical Outcomes in Men With Established Cardiovascular Disease in the Atherothrombosis I...William Boden, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- The Case for Optimal Medical Therapy First in Most!CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Conservative Management Is Appropriate for Most Elderly Patients With NSTEMI2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Increased Residual Cardiovascular Risk in US Veterans and Monerately-Elevated Baseline Triglycerides and Well-Controlled LDL-C Levels on Statins2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Authored Content
- ACCEL Lite: What Does a Cardiologist Need To Know About Chronic Kidney Disease?June 2023
- Letter by Boden Regarding Article, “Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials”April 2020
- Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe IschemiaMarch 2020
Press Mentions
Experimental Cholesterol-Lowering Pill May Offer New Option for MillionsFebruary 4th, 2026
Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRESeptember 23rd, 2024
Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the UnconvincedSeptember 20th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









